Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Isavuconazonium sulfate

EU orphan designation number: EU/3/14/1284   
Active ingredient: Isavuconazonium sulfate
Indication: Treatment of invasive aspergillosis
Sponsor: Basilea Medical Ltd
c/o Cox Costello & Horne Limited, Langwood House, 63-81 High Street, Rickmansworth, Hertfordshire WD3 1EQ, United Kingdom
EU Centralised marketing authorisation: A centralised EU marketing authorisation has been obtained under the name Cresemba on 15/10/2015 with the number EU/1/15/1036

   Public summary of scientific opinion     EPAR

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
08/07/2014 Orphan designation EMA/OD/009/14 (2014)4836 of 04/07/2014